EmergencyKT: New Onset Diabetes, Non-DKA Definition: ED patient with newly discovered hyperglycemia, >200 mg %

Size: px
Start display at page:

Download "EmergencyKT: New Onset Diabetes, Non-DKA Definition: ED patient with newly discovered hyperglycemia, >200 mg %"

Transcription

1 EmergencyKT: New Onset, Non-DKA Definition: ED patient with newly discovered hyperglycemia, >200 mg % Obtain: CBCD EP1 VBG Serum Ketone Hemoglobin A1c (for follow up) UA β-hcg (female at risk for pregnancy) Asymptomatic Symptomatic Symptomatic Without polydipsia/polyuria (P/P) Polydipsia/polyuria (P/P) Polydipsia/polyuria (P/P) Serum glucose < 250mg % Serum glucose < 400 mg/dl Serum glucose mg/dl No admittable or serious Anion Gap < 15 Anion Gap < 15 concomitant illness Creatinine < 1.5 Creatinine < 1.5 No admittable or serious No admittable or serious concomitant illness concomitant illness ED Treatment: ED Treatment: ED Treatment: None liters rmal saline liters rmal saline units Humolog insulin units Humolog insulin subcutaneous subcutaneous 3. Recheck EP1 in 1-2 hours 3. Recheck EP1 in 2 hours Disposition: Disposition: Disposition: 1. Brief diabetes education and 1. Glucose<300 mg % (ideally <250) 1. Glucose<300 mg % (ideally <250) diabetes discharge documents 2. Patient competent, good home 2. Patient competent, good home setting setting 2. Follow-up with PCP or urgent 3. Brief diabetes education and 3. Brief diabetes education and medicine clinic <7 days if diabetes discharge documents diabetes discharge documents PCP 4. Start metformin 500 mg. qd 4. Start metformin 500 mg. qd 3. If clinic follow up available 5. Follow-up with PCP or urgent 5. Follow-up with PCP or urgent consider referral to Adele Corbin medicine clinic <7 days if medicine clinic <7 days if (at Hoxworth diabetes clinic) for PCP PCP urgent DM follow up care. 6. Referral to Adele Corbin (at 6. Referral to Adele Corbin (at Call and leave Hoxworth diabetes clinic) for Hoxworth diabetes clinic) for up to date patient contact urgent DM follow up. Call urgent DM follow up. Call information and leave and leave up to date patient contact up to date patient contact information information

2 EmergencyKT: Use of HbA1c in the Emergency Department What is a Hemoglobin A1c (HbA1c)? HbA1c represents a patient s average glucose level over the last 1-4 months. HbA1c measures the percentage of glycosylated hemoglobin in the blood and thus reflects the average glucose level over the life of a red blood cell (120 days) and the hemoglobin it contains. Because of the constant turning over of red blood cells, more recent glucose levels (ie. the last few weeks) have a greater effect on the HbA1c value than do those from 8 or 12 weeks ago. It is estimated that half of an HbA1c value is attributable to the previous month s glucose level, a further quarter to the month before that, and the other quarter to the two months before that. Since the HbA1c value is t influenced by daily fluctuations in blood glucose concentration, it should t be used to monitor day-to-day blood glucose concentrations and to adjust insulin treatment. Moreover, the HbA1c value may t reflect the day-to-day presence or absence of hyperglycemia and/or hypoglycemia. HbA1c level may be falsely increased in patients with: kidney failure, chronic excessive alcohol intake (Vit B12 and foliate deficiency), untreated iron deficient anemia, and hypertriglyceridemia HbA1c level may be falsely decreased in patients with: acute or chronic blood loss, sickle cell disease, hemolytic anemia/thalassemia. Why obtain an HbA1c in the Emergency Department? Without primary care and proper diabetes management it is extremely difficult for many diabetics to control their glucose levels. It is this lack of glycemic control that is ultimately responsible for the host of debilitating and potentially life threatening health complications associated with poorly controlled diabetes. Diabetic patients who present to the emergency department (and who lack adequate primary care or who are in need of improved diabetes management, education and/or follow up) should have their HbA1c level obtained. The result can then be used to assess the patient s current glycemic control and determine their urgency of needed follow up. The implementation of this tool could significantly reduce the number of unnecessary emergency department visits by decreasing the number of diabetic patients who use the emergency department as a means of obtaining primary care and by decreasing the incidence and severity of diabetic related complications that require emergency department treatment. This also has the potential to reduce costs by decreasing the number of emergency department visits and their related work ups. HbA1c % Average Serum Glucose mg/dl < > 12 < > 314 Marginally Kwn Diabetic Increased risk for severe hypoglycemia adverse events including coma, seizures and death Excellently Controlled Well Controlled Take action to lower average glucose levels Note: HbA1c < 8% may be appropriate for patients with a history of severe hypoglycemia, advanced age or severe comorbidities. Poorly Very Poorly Severely Elevated Extremely Poor Management New Onset Hyperglycemia Unlikely (Pre Diabetic) Increased risk for diabetes and diabetes related complications Borderline

3 Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Control and Complications Trial. The Journal of the American Medical Association. 1996; 17: Ginde AA, Talley BE, Trent SA. Raja AS, Sullivan AF, Camargo CA. Referral of Discharged Emergency Department Patients to Primary and Specialty Care Follow-up. Journal of Emergency Medicine. May 2011; Retrieved online on April 9, 2011 from website: Standards of Medical Care in Care. January 2010; 33:

4 EmergencyKT: Disposition for Hyperglycemic/Diabetic Patients Discharged from the ED 1. Hyperglycemia identified and treated 2. All applicable lab work obtained: CBCD, EP1, Mag, Phos, VBG, HbA1c, Serum Ketones, UA/Preg 3. Underlying cause of blood sugar variation/infection identified and treated 1. Glucose ideally < No Recent Hypoglycemia 3. Vital Signs Stable 4. Ability to tolerate PO 5. Anion Gap < Competent to perform basic diabetic care (able to recognize hyperglycema and hypoglycemia) HbA1c % Control card. Type 2 - Cell Biology. Obtained online on April 14 from website: type-2-diabetes-cell-biology < >12 Increased Hypoglycemic Risk (consider DM clinic referral) yes Consider Diabetic Clinic Referral yes Consider Admission (for intensive glucose management) Referral to Adele Corbin (@ Hoxworth diabetes clinic) for urgent DM follow up. Call and leave up to date patient contact Information, brief patient history and current HbA1c result (if available at time of discharge) Follow up with PCP < 7 days If PCP, consider urgent medicine clinic referral Ensure that patient has all needed diabetic supplies including glucometers, and Rx refill for supplies if needed (free glucometers and generic Rx forms for common medications and DM supplies can be found in the radio room, see DM Committee member if ne are available). Brief diabetes education and discharge instructions specific for diabetes (found on CPQE). Follow up with PCP If PCP, consider urgent medicine clinic referral

5 Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Control and Complications Trial. The Journal of the American Medical Association. 1996; 17: Ginde AA, Talley BE, Trent SA. Raja AS, Sullivan AF, Camargo CA. Referral of Discharged Emergency Department Patients to Primary and Specialty Care Follow-up. Journal of Emergency Medicine. May 2011; Retrieved online on April 9, 2011 from website: Standards of Medical Care in Care. January 2010; 33:

DIABETES MELLITUS. IAP UG Teaching slides

DIABETES MELLITUS. IAP UG Teaching slides DIABETES MELLITUS 1 DIABETES MELLITUS IN CHILDREN Introduction, Definition Classification, pathogenesis Clinical features Investigations and diagnosis Therapy and follow up Complications Carry home message

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes

More information

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014 DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol Glycemic Task Force September 2014 Hyperglycemic Crises: Pathophysiology DKA HHS Hyperglycemia DKA HHS Umpierrez, In Shoemaker,

More information

DKA Adult ICU Powerplan

DKA Adult ICU Powerplan DKA Adult ICU Powerplan Key Points for ED to ICU DKA power plan In addition to NS fluids and maintenance the regular insulin drip will either already be infusing from ED or needs to be initiated. Regular

More information

Estimation of Blood Glucose level. Friday, March 7, 14

Estimation of Blood Glucose level. Friday, March 7, 14 Estimation of Blood Glucose level Importance Diagnosis and treatment of carbohydrate metabolism disorders Monitor the effectivity and response to an ongoing treatment procedure Control mechanism Insulin

More information

Improved IPGM: Demonstrating the Value to both Patients and Hospitals

Improved IPGM: Demonstrating the Value to both Patients and Hospitals Improved IPGM: Demonstrating the Value to both Patients and Hospitals Osama Hamdy, MD, PhD, FACE Medical Director, Inpatient Diabetes Program Joslin Diabetes Center Harvard Medical School, Boston, MA Cost

More information

Uncomplicated Diabetes Mellitus in Dogs Basics

Uncomplicated Diabetes Mellitus in Dogs Basics Glendale Animal Hospital 623-934-7243 www.familyvet.com Uncomplicated Diabetes Mellitus in Dogs Basics OVERVIEW Increased levels of glucose (sugar) in the blood (known as hyperglycemia ) when the dog has

More information

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates Juan Pablo Frias, MD President and CEO, National Research Institute, Los Angeles, CA Clinical Faculty, University

More information

Non-insulin treatment in Type 1 DM Sang Yong Kim

Non-insulin treatment in Type 1 DM Sang Yong Kim Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay

More information

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1 Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies

More information

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016 Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features

More information

APPENDIX American Diabetes Association. Published online at

APPENDIX American Diabetes Association. Published online at APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no

More information

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members 2017 Diabetes Program Evaluation Our mission is to improve the health and quality of life of our members Diabetes Program Evaluation Program Title: Diabetes Program Evaluation Period: January 1, 2017 December

More information

Distinguishing T1D vs. T2D in Childhood: a case report for discussion

Distinguishing T1D vs. T2D in Childhood: a case report for discussion Distinguishing T1D vs. T2D in Childhood: a case report for discussion Alba Morales, MD Associate Professor of Pediatrics Division of Pediatric Endocrinology and Diabetes Disclosure I have no financial

More information

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations. Askiel Bruno, MD, MS Protocol PI

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations. Askiel Bruno, MD, MS Protocol PI Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations Askiel Bruno, MD, MS Protocol PI Hypoglycemia Protocol General Concepts The hypoglycemia prevention protocol

More information

Diabetic Ketoacidosis

Diabetic Ketoacidosis Diabetic Ketoacidosis Definition: Diabetic Ketoacidosis is one of the most serious acute complications of diabetes. It s more common in young patients with type 1 diabetes mellitus. It s usually characterized

More information

Q99: At what plasma glucose level would glycosuria be expected? Q101: What is the cause of polydipsia in the hypoglycemia?

Q99: At what plasma glucose level would glycosuria be expected? Q101: What is the cause of polydipsia in the hypoglycemia? Q99: At what plasma glucose level would glycosuria be expected? Q100: What is the cause of polyemia in hyperglycemia? Q101: What is the cause of polydipsia in the hypoglycemia? Q102: What is the effect

More information

Chapter 37: Exercise Prescription in Patients with Diabetes

Chapter 37: Exercise Prescription in Patients with Diabetes Chapter 37: Exercise Prescription in Patients with Diabetes American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:

More information

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It Cassie Brady, MD Assistant Professor of Pediatrics Division of Endocrinology and Diabetes Monroe Carell Junior Children s Hospital

More information

Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State. Adam Bursua, Pharm.D., BCPS

Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State. Adam Bursua, Pharm.D., BCPS Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State Adam Bursua, Pharm.D., BCPS Objectives Describe the epidemiology of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar

More information

Figure 2.1: Glucose meter

Figure 2.1: Glucose meter CHAPTER TWO: MONITORING TECHNOLOGIES 2.1 Introduction Glucose monitoring is a method of self-testing glucose (blood sugar) levels for the management of diabetes. Traditionally, it involves pricking the

More information

Diabetes Care Program of Nova Scotia (DCPNS)

Diabetes Care Program of Nova Scotia (DCPNS) 1! Diabetes Care Program of Nova Scotia (DCPNS) Triage and Discharge Guidelines for Initial and Follow-Up Appointments in Diabetes Centres (DCs) in Nova Scotia, 2016 Frequently Asked Questions (FAQs) Background:

More information

Incorporating CGM Into Clinical Decision Making. Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA

Incorporating CGM Into Clinical Decision Making. Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA Incorporating CGM Into Clinical Decision Making Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA 1 Limitations of Current Glucose Monitoring Methods A1c Standard

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies 1979 Advances in Diabetes Care Technologies 2015 Introduction Insulin pump use: ~ 20% - 30% of patients with T1DM < 1% of insulin-treated patients with T2DM 2007 FDA estimates ~375,000 insulin pumps for

More information

Chapter Goal. Learning Objectives 9/12/2012. Chapter 25. Diabetic Emergencies

Chapter Goal. Learning Objectives 9/12/2012. Chapter 25. Diabetic Emergencies Chapter 25 Diabetic Emergencies Chapter Goal Use assessment findings to formulate field impression & implement treatment plan for patients with diabetic emergencies Learning Objectives Describe pathophysiology

More information

ACUTE METABOLIC COMPLICATIONS IN DIABETES Arleta Rewers, MD, PhD

ACUTE METABOLIC COMPLICATIONS IN DIABETES Arleta Rewers, MD, PhD CHAPTER 17 ACUTE METABOLIC COMPLICATIONS IN DIABETES Arleta Rewers, MD, PhD Dr. Arleta Rewers is Associate Professor, Department of Pediatrics at University of Colorado Denver School of Medicine, Aurora,

More information

Influence of Special Needs: Presentation for IOM Committee on Examination of the Adequacy of Food Resources and SNAP Benefits

Influence of Special Needs: Presentation for IOM Committee on Examination of the Adequacy of Food Resources and SNAP Benefits Influence of Special Needs: Presentation for IOM Committee on Examination of the Adequacy of Food Resources and SNAP Benefits Hilary Seligman, MD, MAS, FACP March 28, 2012 Objective Using diabetes as a

More information

LOW SUGAR: CAUSES, COMPLICATIONS AND MANAGEMENT OF HYPOGLYCEMIA

LOW SUGAR: CAUSES, COMPLICATIONS AND MANAGEMENT OF HYPOGLYCEMIA LOW SUGAR: CAUSES, COMPLICATIONS AND MANAGEMENT OF HYPOGLYCEMIA Anne Leake, PhD, APRN-Rx, BC-ADM ECHO Diabetes Learning Group 3/28/2018 Objectives 1. Identify common preventable causes of hypoglycemia

More information

Diabetic Ketoacidosis

Diabetic Ketoacidosis 6/9/2018 Management of Diabetic Ketoacidosis STAT 183 Individual Project Prepared for: Dr. Karen Huaying Xu Prepared by: Albert Sosa UNIVERSITY OF CALIFORNIA, RIVERSIDE Table of Contents I Introduction

More information

Neurodevelopmental Risk?

Neurodevelopmental Risk? Normal Newborn During transitional hypoglycemia normal newborns have an enhanced ketogenic response to fasting. Newborn brains have enhanced capability to use ketone bodies for fuel Allows newborns to

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus Journal Club (May 2013) Sara Al-Sharhan, Pharm D intern-

More information

Nursing Care of the Resident with Diabetes Mellitus

Nursing Care of the Resident with Diabetes Mellitus Nursing Care of the Resident with Diabetes Mellitus Level III Definitions Diabetes is a disorder in which there is relative or absolute lack of insulin. Among other things, glucose (sugar) from food cannot

More information

39 year old F with sickle cell anemia presenting with pain crisis. Jess Hwang 11/8/12

39 year old F with sickle cell anemia presenting with pain crisis. Jess Hwang 11/8/12 39 year old F with sickle cell anemia presenting with pain crisis Jess Hwang 11/8/12 HPI Knee and back pain typical of usual crises Nausea and vomiting 2 days prior to admission Had previously been on

More information

Hypoglycemia Reduction STARTER PACK WEBINAR #1

Hypoglycemia Reduction STARTER PACK WEBINAR #1 Hypoglycemia Reduction STARTER PACK WEBINAR #1 Why is it important to reduce hypoglycemia? Why Hypoglycemia Reduction? Key Statistics Overall 29% reduction in ADEs since 2010 Hypoglycemia still occurs

More information

Diabetic Equipment and Supplies

Diabetic Equipment and Supplies Diabetic Equipment and Supplies Chapter.1 Enrollment..................................................................... -2.2 Benefits, Limitations, and Authorization Requirements...........................

More information

2015 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

2015 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members 2015 Diabetes Program Evaluation Our mission is to improve the health and quality of life of our members Diabetes Care Program Evaluation Program Title: Diabetes Care Program Evaluation Period: January

More information

American Diabetes Association 2018 Guidelines Important Notable Points

American Diabetes Association 2018 Guidelines Important Notable Points American Diabetes Association 2018 Guidelines Important Notable Points The Standards of Medical Care in Diabetes-2018 by ADA include the most current evidencebased recommendations for diagnosing and treating

More information

Diabetes Case Study: Co-morbidity of Nonadherence

Diabetes Case Study: Co-morbidity of Nonadherence Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18 Comorbidity of Diabetes Case Study Objective: the learner will discuss an underreported comorbidity of

More information

Initiation and Titration of Insulin in Diabetes Mellitus Type 2

Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Greg Doelle MD, MS April 6, 2016 Disclosure I have no actual or potential conflicts of interest in relation to the content of this lecture.

More information

Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18

Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18 Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18 Comorbidity of Diabetes Case Study Objective: the learner will discuss an underreported comorbidity of

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies 1979 Advances in Diabetes Care Technologies 2015 Introduction Roughly 20% - 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the US FDA estimated

More information

WILL YOU USE HBA1C TO SCREEN & MONITOR DIABETES? Dr. Amany Mousa

WILL YOU USE HBA1C TO SCREEN & MONITOR DIABETES? Dr. Amany Mousa WILL YOU USE HBA1C TO SCREEN & MONITOR DIABETES? Dr. Amany Mousa Diabetes is clinically well defined by glycation of proteins 1. True 2. false So far, diabetes has been defined as a clinical condition

More information

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Pharmacy Coverage Guidelines are subject to change as new information becomes available. Metformin tablet SR 24-hour modified release oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit

More information

Peripartum and Postpartum Management of Diabetes

Peripartum and Postpartum Management of Diabetes Peripartum and Postpartum Management of Diabetes General Principles Glucose goal ~ 100 mg/dl (70-110 mg/dl) Labor is EXERCISE with increased metabolic demands. Insulin requirements decrease however the

More information

Use of Real-World Data for Population Surveillance and Monitoring. Kasia Lipska, MD Yale School of Medicine November 17 th, 2018.

Use of Real-World Data for Population Surveillance and Monitoring. Kasia Lipska, MD Yale School of Medicine November 17 th, 2018. Use of Real-World Data for Population Surveillance and Monitoring Kasia Lipska, MD Yale School of Medicine November 17 th, 2018 Grants: NIH Disclosures Consultant: Health Services Advisory Group (HSAG)

More information

Key Elements in Managing Diabetes

Key Elements in Managing Diabetes Key Elements in Managing Diabetes Presentor Disclosure No conflicts of interest to disclose Presented by Susan Cotey, RN, CDE Lennon Diabetes Center Stephanie Tubbs Jones Health Center Cleveland Clinic

More information

Journal Club September 29, Vanessa AKIKI PGYlII Internal Medicine

Journal Club September 29, Vanessa AKIKI PGYlII Internal Medicine Journal Club September 29, 2017 Vanessa AKIKI PGYlII Internal Medicine AUBMC 2017 Case Presentation 41-year-old man who was diagnosed with type 1 diabetes 21 years ago presents to your clinic. He believes

More information

Learning Objectives. At the conclusion of this module, participants should be better able to:

Learning Objectives. At the conclusion of this module, participants should be better able to: Learning Objectives At the conclusion of this module, participants should be better able to: Treat asymptomatic neonatal hypoglycemia with buccal dextrose gel Develop patient-specific approaches to intravenous

More information

Diabetes Self-Management Education Record

Diabetes Self-Management Education Record Diabetes Self-Management Education Record Patient Label Record level of competence and Initial: O=outcomes met; RT=reinforce teaching; NA=not applicable; P=prior knowledge Clinical Outcomes Information

More information

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES DEFINITION -Glucose >250 mg/dl*, anion gap > 16, + ketones * Glucose < 250 does not exclude DKA especially if anion gap >

More information

HIMSS Davies Enterprise Award Submission

HIMSS Davies Enterprise Award Submission HIMSS Davies Enterprise Award Submission Applicant Organization: St. Clair Hospital Organization s Address: 1000 Bower Hill Road, Pittsburgh, PA, 15243 Submitter s Name: Richard J. Schaeffer Submitter

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT *****ALSO ORDER SUB ACUTE DKA IV FLUIDS REGIMEN & SUB ACUTE ELECTROLYTE REPLACEMENT on separate forms ***** Condition/Status For purpose of this DKA Regimen, DKA is considered clear

More information

Insulinoma - 72 hour Fast Protocol - RNS Endocrinology

Insulinoma - 72 hour Fast Protocol - RNS Endocrinology Page 1 of 9 - RNS Endocrinology Test name 72 hour fast Alternate test names. Related Tests Mixed meal test Indication(s) Differential diagnosis of causes of hypoglycaemia. Hypoglycaemia is rare in persons

More information

DKA/HHS Pathway Phase 1 (Adult) Insulin Potassium Bicarbonate

DKA/HHS Pathway Phase 1 (Adult) Insulin Potassium Bicarbonate Approved by Diabetes Steering Committee, MMC, 2015 DKA/HHS Pathway Phase 1 (Adult) DKA Diagnostic Criteria (See page 3 for more details): Blood glucose >250 mg/dl, Arterial ph

More information

Metformin Hydrochloride

Metformin Hydrochloride Metformin Hydrochloride 500 mg, 850 mg, 500 mg LA and 750 mg LA Tablet Description Informet is a preparation of metformin hydrochloride that belongs to a biguanide class of oral antidiabetic drugs. Metformin

More information

SYNOPSIS. Administration: subcutaneous injection Batch number(s):

SYNOPSIS. Administration: subcutaneous injection Batch number(s): SYNOPSIS Title of the study: A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top

More information

associated with serious complications, but reduce occurrences with preventive measures

associated with serious complications, but reduce occurrences with preventive measures Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences

More information

Individualizing Treatment Plans for Older Adults With T2DM

Individualizing Treatment Plans for Older Adults With T2DM Individualizing Treatment Plans for Older Adults With T2DM Key Slides from the Interactive Newsletter Hypoglycemia y in Older Adults Particularly dangerous, especially for those on insulin or secretagogues

More information

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center - Phase: Begin Immediately/Emergency Center Weight PHYSICIAN S Allergies Admit/Discharge/Transfer Patient Status Requested Location: MICU, Pt Status: Inpatient (LOS > 2 midnights) Requested Location: 5E

More information

CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017

CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017 CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017 DKA at organ level 3 Diabetic Ketoacidosis Characteristics Ketones positive Anion Gap > 12 (High) Blood Sugar > 14 (High) Bicarbonate

More information

Brigham and Women s Hospital Type 2 Diabetes Management Program Physician Pharmacist Collaborative Drug Therapy Management Protocol

Brigham and Women s Hospital Type 2 Diabetes Management Program Physician Pharmacist Collaborative Drug Therapy Management Protocol Brigham and Women s Hospital Type 2 Diabetes Management Program Physician Pharmacist Collaborative Drug Therapy Management Protocol *Please note that this guideline may not be appropriate for all patients

More information

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2 Diabetes Dilemmas: Using Technology To Solve Clinical Conundrums Stephen E. Gitelman, MD UCSF A teenager with type 1 diabetes for 5 years comes into your office for a follow- up visit. You want to review

More information

Sponsor: Sanofi Drug substance(s): Lantus /insulin glargine. Study Identifiers: U , NCT Study code: LANTUL07225

Sponsor: Sanofi Drug substance(s): Lantus /insulin glargine. Study Identifiers: U , NCT Study code: LANTUL07225 These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor: Sanofi Drug substance(s):

More information

Test strip reading - Cats Negative Trace

Test strip reading - Cats Negative Trace WHAT I LEARNED FROM MY DIABETIC CAT: DIAGNOSIS AND MONITORING Ellen N. Behrend, VMD, PhD, DACVIM Although diagnosis of diabetes mellitus (DM) is usually a no-brainer, it can sometimes be difficult, especially

More information

Physical Activity/Exercise Prescription with Diabetes

Physical Activity/Exercise Prescription with Diabetes Physical Activity/Exercise Prescription with Diabetes B R AD H I NTERMEYER C E P A C SM S A NFORD H E ALTH C A RDIAC R E H AB A N D D I ABE TES E XE RCISE The adoption and maintenance of physical activity

More information

JMSCR Vol 06 Issue 10 Page October 2018

JMSCR Vol 06 Issue 10 Page October 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i10.44 Original Research Article Evaluation

More information

AACE Module on Patient Safety in Inpatient Diabetes Care

AACE Module on Patient Safety in Inpatient Diabetes Care AACE Module on Patient Safety in Inpatient Diabetes Care Richard Hellman, MD, FACP, FACE Past President, American Association of Clinical Endocrinologists Clinical Professor of Medicine, University of

More information

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE Management of DM in Older Adults: It s not all about sugar! Peggy Odegard, Pharm.D., BCPS, CDE Who needs treatment for DM? 87 year old, frail male with moderately severe dementia living in NH with persistent

More information

Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς

Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς Αναστασία Θανοπούλου Επίκουρη Καθηγήτρια Β Παθολογικής Κλινικής Πανεπιστημίου Αθηνών Διαβητολογικό Κέντρο, Ιπποκράτειο Νοσοκομείο

More information

Introduction. Methods

Introduction. Methods A New Perspective On A Difficult Discharge: Ensuring the newly diagnosed diabetic patient gets the proper prescriptions when it s time to go home. Ashley Carter, PGY 3 Introduction A hospitalized patient

More information

Food Insecurity & Health

Food Insecurity & Health Food Insecurity & Health Hilary Seligman, MD, MAS, FACP April 20, 2012 Objectives 1. Briefly describe associations between food insecurity and health among children and adults 2. Using diabetes as a case

More information

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction

More information

These results are supplied for informational purposes only.

These results are supplied for informational purposes only. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov

More information

The Diabetic Athlete. Matt Bayes, MD, CAQSM BlueTail Medical Group St. Louis, MO

The Diabetic Athlete. Matt Bayes, MD, CAQSM BlueTail Medical Group St. Louis, MO The Diabetic Athlete Matt Bayes, MD, CAQSM BlueTail Medical Group St. Louis, MO Thanks to: David Olson, MD University of Minnesota Objectives At the conclusion of this lecture you will be able to: Discuss

More information

Deepika Reddy MD Department of Endocrinology

Deepika Reddy MD Department of Endocrinology Deepika Reddy MD Department of Endocrinology Management of hyperglycemic crisis Review need for inpatient glycemic control Brief overview of relevant trials Case based review of diabetes management strategies/review

More information

About the Highmark Foundation

About the Highmark Foundation About the Highmark Foundation The Highmark Foundation, created in 2000 as an affiliate of Highmark Inc., is a charitable organization and a private foundation that supports initiatives and programs aimed

More information

DIABETES WITH PREGNANCY

DIABETES WITH PREGNANCY DIABETES WITH PREGNANCY Prof. Aasem Saif MD,MRCP(UK),FRCP (Edinburgh) Maternal and Fetal Risks Diabetes in pregnancy is associated with risks to the woman and to the developing fetus. Maternal and Fetal

More information

Your pet s diabetes is manageable

Your pet s diabetes is manageable BLOOD GLUCOSE MONITORING SYSTEM Your pet s diabetes is manageable Treatment and Monitoring Plan for: Pet s Name: Clinic Name: Primary Vet: Clinic Phone No.: Clinic Email: Emergency Phone No: Today s Date:

More information

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:

More information

DIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor

DIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor DIABETES AND PREGNANCY CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor OBJECTIVES Describe targets for blood glucose in pregnancy Discuss the risks to baby if blood glucose

More information

Diagnosis and Management of Type 2 Diabetes Mellitus in Adults

Diagnosis and Management of Type 2 Diabetes Mellitus in Adults Quality Improvement Support: Diagnosis and Management of Type 2 Diabetes Mellitus in Adults The Aims and Measures section is intended to provide guideline users with a menu of measures for multiple purposes,

More information

RN Diabetes Medication Titration Protocol

RN Diabetes Medication Titration Protocol Metformin (Glucophage) Biguanide Medication titration: Time 0 APC or MD Start Metformin 500mg (500mg in the morning, taken with food) Week 1 Week 2 Metformin 1000mg (500mg in the morning and 500mg in the

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Acute Diabetic Ketoacidosis Condition/Status ***(NOTE)*** For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS

More information

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes

More information

A collaborative approach to managing Diabetes in Long Term Care

A collaborative approach to managing Diabetes in Long Term Care A collaborative approach to managing Diabetes in Long Term Care Diabetes is a top three disease state in OMNI homes Lack of standardized diabetes care for residents in LTC Lack of Evidence Based Guidelines

More information

Diabetes, sugar. Greenville Veterinary Clinic LLC 409 E. Jamestown Rd. Greenville, PA (724)

Diabetes, sugar. Greenville Veterinary Clinic LLC 409 E. Jamestown Rd. Greenville, PA (724) Greenville Veterinary Clinic LLC 409 E. Jamestown Rd. Greenville, PA 16125 (724) 588-5260 Feline diabetes mellitus Diabetes, sugar AffectedAnimals: Most diabetic cats are older than 10 years of age when

More information

Learning Objectives. Perioperative SWEET Success

Learning Objectives. Perioperative SWEET Success Perioperative SWEET Success PERIOPERATIVE SWEET SUCCESS PRESENTED BY: KENDRA MARTIN, RN, BSN, CDE JENNIFER SIMPSON, RN, BC-ADM, MSN, CNS Disclosure to Participants Notice of Requirements For Successful

More information

A Children s Bedtime Story

A Children s Bedtime Story A Children s Bedtime Story Setting: University Medical Center, Big Town, USA Scenario: 0500, last admission of the night, 10 previous admissions, all tucked in for the night Patient: 75 year old male with

More information

Discharge Checklist. Patient Education Transplant Services. For a kidney/pancreas transplant

Discharge Checklist. Patient Education Transplant Services. For a kidney/pancreas transplant Patient Education Discharge Checklist For a kidney/pancreas transplant Are you ready to leave the hospital with your new kidney or pancreas? You will want to make sure you have done all the necessary planning

More information

Benefit Criteria for Diabetic Equipment and Supplies Home Health Services Changing July 1, 2011

Benefit Criteria for Diabetic Equipment and Supplies Home Health Services Changing July 1, 2011 Benefit Criteria for Diabetic Equipment and Supplies Home Health Services Changing July 1, 2011 Information posted May 13, 2011 Effective for dates of service on or after July 1, 2011, the benefit criteria

More information

Improving the Accuracy of Hemoglobin A 1c. : Your Help Is Needed

Improving the Accuracy of Hemoglobin A 1c. : Your Help Is Needed Improving the Accuracy of Hemoglobin A 1c : Your Help Is Needed Kristina Jackson Behan, PhD, MT(ASCP) (Clinical Laboratory Sciences Program, University of West Florida, Pensacola, FL) DOI: 10.1309/RTVTWPYPTPA5YAGU

More information

How Doctors Choose Medicines when Treating Patients with Type 2 Diabetes

How Doctors Choose Medicines when Treating Patients with Type 2 Diabetes HARVARD MEDICAL SCHOOL How Doctors Choose Medicines when Treating Patients with Type 2 Diabetes Richard W. Grant MD MPH Endocrine Society Beta Cell meeting January 9-10, 2009 Outline Background Observed

More information

DEMYSTIFYING INSULIN THERAPY

DEMYSTIFYING INSULIN THERAPY DEMYSTIFYING INSULIN THERAPY ASHLYN SMITH, PA-C ENDOCRINOLOGY ASSOCIATES SCOTTSDALE, AZ SECRETARY, AMERICAN SOCIETY OF ENDOCRINE PHYSICIAN ASSISTANTS ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING

More information

APIDRA (insulin glulisine) injection vial APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector

APIDRA (insulin glulisine) injection vial APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8''

VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8'' IMC Didactic Case-Diabetes Mellitus Chief Complaint "I was recently diagnosed with diabetes and would like to have my blood sugar tested. I think that my blood sugar is running low because I have the shakes

More information

Diabetes Mellitus Case Study

Diabetes Mellitus Case Study COLORADO STATE UNIVERSITY Diabetes Mellitus Case Study Medical Nutrition Therapy By: Emily Lancaster 9/28/2012 [Type the abstract of the document here. The abstract is typically a short summary of the

More information

23-Aug-2011 Lixisenatide (AVE0010) - EFC6014 Version number: 1 (electronic 1.0)

23-Aug-2011 Lixisenatide (AVE0010) - EFC6014 Version number: 1 (electronic 1.0) SYNOPSIS Title of the study: A randomized, double-blind, placebo-controlled, parallel-group, multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top of metformin

More information

Diabetes Update: Intensifying Insulin Therapy Nuts, Bolts and Other Items

Diabetes Update: Intensifying Insulin Therapy Nuts, Bolts and Other Items Diabetes Update: Intensifying Insulin Therapy Nuts, Bolts and Other Items Hayley A. Miller, MD Physician, Internal Medicine, Diabetes and Metabolism, Sandy Clinic, Intermountain Healthcare Objectives:

More information